Cat owners asked to share pets' quirks for genetic study
Cat owners are being asked share their pet's quirky traits and even post researchers their fur in an effort to shed light on how cats' health and behaviour are influenced by their genetics.
The scientists behind the project, Darwin's Cats, are hoping to enrol 100,000 felines, from pedigrees to moggies, with the DNA of 5,000 cats expected to be sequenced in the next year.
The team say the goal is to produce the world's largest feline genetic database.
'Unlike most existing databases, which tend to focus on specific breeds or veterinary applications, Darwin's Cats is building a diverse, large-scale dataset that includes pet cats, strays and mixed breeds from all walks of life,' said Dr Elinor Karlsson, the chief scientist at the US non-profit organisation Darwin's Ark, director of the vertebrate genomics group at the Broad Institute of MIT and Harvard and associate professor at the UMass Chan Medical School.
'It's important to note, this is an open data project, so we will share the data with other scientists as the data set grows.' she added.
The project follows on the heels of Darwin's Dogs, a similar endeavour that has shed light on aspects of canine behaviour, disease and the genetic origins of modern breeds.
Darwin's Cats was launched in mid-2024 and already has more than 3,000 cats enrolled, although not all have submitted fur samples.
Participants from all parts of the world are asked to complete a number of free surveys about their pet's physical traits, behaviour, environment, and health.
However, at present, DNA kits – for owners to submit fur samples – can be sent only to US residents, and a donation of $199 (£160) is requested to cover the cost of sequencing and help fund the research.
Karlsson added the team had developed a method to obtain high-quality DNA from loose fur without needing its roots – meaning samples can simply be collected by brushing.
The researchers hope that by combining insights from cats' DNA with the survey results they can shed light on how feline genetics influences what cats look like, how they act and the diseases they experience.
'Understanding the genetics behind personality traits could even shed light on human neurodevelopmental conditions,' said Karlsson.
The team also hopes to learn more about the genetic diversity of different breeds and unpick the ancestry of modern cats, with Karlsson adding she is particularly interested in many-toed cats.
'I'm really curious to find out how common this trait is in different parts of the world. I hope one day we might be able to combine that information with genetics to trace this trait back to its origins,' she said.
A spokesperson for the charity International Cat Care (iCatCare), which is not involved in the work, said:
'We're really interested in the collaborative approach of Darwin's Ark, particularly in encouraging pet owners as community scientists to help advance the collective scientific understanding of cats as a species.'
Dr Jeffrey Schoenebeck, of the Roslin Institute at the University of Edinburgh, also welcomed the . scheme. 'This is an important project that has the potential to improve our understanding of companion animals, the diseases that cause their morbidities, and the very nature of feline domestication,' he said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Telegraph
03-05-2025
- Telegraph
Two weeks of prostate cancer radiotherapy still saves lives, study finds
For many patients, radiotherapy is a standard treatment option that offers outcomes comparable to surgery, particularly for localised disease but schedules typically span several weeks, which can be burdensome for patients and put pressure on healthcare systems. For the new trial, 1,200 men with localised cancer were given either a short course of seven sessions over two and a half weeks, or a standard course of 39 sessions over eight weeks. Results showed that 72 per cent of men having the shorter treatment did not see their cancer return and did not need more treatment within the next 10 years, compared to 65 per cent of men in the standard group. Overall survival for the two-week group was 81 per cent compared with 79 per cent for traditional treatment. For both groups four per cent of men died from their cancer in the 10-year follow up. The shorter treatment group needed a total radiation of 42.7 gy (the unit for absorbed dose) compared to 72 gy for the eight-week group. Side effects were similar in both groups and were mostly mild to moderate. 'These findings confirm that the shorter course does not increase long-term side effects and provides equally durable cancer control', added Dr Camilla Thellenberg-Karlsson, of Umeå University. 'A major win' for patients The findings were welcomed by charities. Simon Grieveson, assistant director of research at Prostate Cancer UK, said: 'We welcome these results. It's fantastic news for men that this has shown the long-term benefits of a shorter course of radiotherapy, meaning that they could still receive the best possible treatment with fewer visits to the hospital. 'We've previously seen similar results from the UK-based PACE B trial, which has shown that using stereotactic ablative body radiotherapy – a form of radiotherapy which delivers high doses of radiation directly to tumours, reducing exposure to healthy tissue around the cancer – can cut down the number of treatment sessions to just five over a two-week period. 'These studies show us that shorter courses of radiotherapy can be just as effective for men compared to the more extensive radiotherapy regimes more commonly used.' The research was presented at ESTRO 2025, the annual congress of the European Society for Radiotherapy and Oncology. Prof Matthias Guckenberger, president of ESTRO, added: 'Shorter treatment schedules mean patients can return to their normal lives more quickly. 'Reducing treatment time to just two and a half week is a major win for both patients and health systems.'
The Guardian
05-04-2025
- The Guardian
Biologist whose innovation saved the life of British teenager wins $3m Breakthrough prize
For the past five years, David Liu – a professor at the Broad Institute of MIT and Harvard, a biomedical research facility in Massachusetts – has marked Thanksgiving by handing over his entire annual salary, after taking care of taxes, to the staff and students in his laboratory. It started as the pandemic broke and Liu heard that students who wanted to cycle instead of taking public transport could not afford bicycles. Given how hard they worked and how little they were paid, Liu stepped in. He couldn't unilaterally raise their incomes, so emailed them Amazon eGift cards. This ran into problems too, however. 'Everyone thought they were being scammed,' he recalls. And so he switched to writing cheques. As the co-founder of several companies, Liu can make ends meet without his Harvard salary, and has set up a charitable foundation to further scientific research. Its coffers are due to swell considerably now that Liu has received the $3m Breakthrough prize for life sciences, which he was presented with on Saturday at the annual awards ceremony in Los Angeles. The Breakthrough prizes, described by their Silicon Valley founders as the Oscars of science, are awarded annually to scientists and mathematicians chosen by committees of previous winners. This year, two further life sciences prizes were given for landmark research on multiple sclerosis and GLP-1 agonists, better known as 'skinny jabs'. Other winners on the night were Dennis Gaitsgory, a mathematician in Bonn, for his work on the Langlands program, an ambitious effort to unify disparate concepts in maths, and more than 13,000 researchers at Cern for testing the modern theory of particle physics. Liu was chosen for inventing two exceptionally precise gene editing tools, namely base editing and prime editing. Base editing was first used in a patient at Great Ormond Street in London, where it saved the life of a British teenager with leukaemia. Scientists have worked on gene editing for more than a decade. Progress, they hope, will lead to therapeutics that correct the mutations responsible for thousands of genetic diseases. But the first generation of gene editing tools had limited success: they were good at disabling faulty genes, but not at correcting them. Base editing allows scientists to make changes to single letters of the genetic code, while prime editing has been compared to the search and replace function in a word processor, giving researchers the power to rewrite whole stretches of DNA. Together, they have enormous potential. 'The vast majority of known pathogenic mutations can now be corrected using prime editing or base editing,' Liu says. Liu grew up in Riverside, California, and traces his interest in science to playing with bugs in his back yard. He went to Harvard and worked with EJ Corey, a Nobel laureate considered one of the greatest chemists of our time. 'That was the start of what turned into a lifelong love of experimental molecular science,' Liu says. 'He encouraged me to follow my passions and curiosity.' His curiosity was not confined to chemistry. Liu read that radio-controlled plane enthusiasts wanted a plane that flew slowly enough to pilot around a room. After working the equations, he built the Wisp, a six-gram carbon fibre plane that zoomed around at a leisurely one mile per hour. Another project merged Lego bricks with the heat sensor from a burglar alarm to produce the 'mouseapult', a device that detected cats and lobbed toy mice in their direction. Video games also featured heavily. In the early 1990s, Liu hung out with Andy Gavin and Jason Rubin, the students behind the games developer Naughty Dog. He tested games and was an occasional voice actor. One performance made it into Way of the Warrior for the 3DO games machine. 'I said something like…' he pauses to adopt a mocking tone '…'my dead grandfather fights better than you'.' A riskier hobby took root while Liu was in hospital recovering from an operation. He wanted to beat blackjack and wrote a simulator to understand the mathematics. Before long, he had worked out a series of card counting techniques and went to Las Vegas to test them. He did so well that he was banned from all MGM Grand casinos and, to use the gaming euphemism, 'back-roomed' twice to be read the Nevada trespass laws. Later, as a professor at Harvard, a group of students persuaded Liu to run a class on card counting. 'The best decision I made about that team was that no members put in their own money and no members took out their own money. It all went back into the fund for us to fly to Las Vegas and pay for our hotel and meals,' he says. 'It was all about the fun of learning something really difficult.' In the lab, Liu was trying to crack a very different problem. Gene editing at the time could disable genes, but not rewrite the letters of the DNA code. But disabling genes would never be enough to treat genetic diseases. 'They need to be treated by fixing the gene,' he says. The first breakthrough came in 2016 when Liu's team described base editing, a way to correct single-letter mutations that account for nearly a third of genetic diseases. The procedure used Crispr guide molecules to find the faulty code and an enzyme to change the aberrant letter. Waseem Qasim, a paediatric immunologist at Great Ormond Street hospital, remembers reading the paper over breakfast the day after it was published. 'My kids were relatively small at the time. I spat on my cornflakes and said, look at this, guys, science fiction!' A follow-up paper in 2019 described prime editing, a less efficient but more powerful technique that in principle can repair nearly all disease-causing mutations. The benefits of base editing became clear in 2022 when Qasim's team became the first in the world to use the procedure on a patient. Alyssa Tapley, a 13-year-old from Leicester, had run out of options after chemotherapy and a bone marrow transplant had failed to treat her leukaemia. The cancer affected her T-cells, a group of immune cells that normally fight infections. The doctors collected T-cells from a healthy donor and modified the genetic code so that when infused into Alyssa they would seek out and attack her cancer cells. The treatment worked: more than two years later, Alyssa remains in complete remission. More than a dozen clinical trials are now under way to test base editing and prime editing. Positive results have already been reported for leukaemia, sickle-cell disease, beta-thallasaemia and high cholesterol. But major hurdles remain. While Alyssa's treatment involved editing cells outside the body and sending them in, most diseases require mutations to be fixed inside the patient. This is a trick scientists have yet to crack. It's not the only problem. Qasim's team is treating more patients in a trial, but when the trial ends, there may be no one to fund future treatments. 'We are going to end up with treatments that work, but that nobody wants to pay for.' Liu is optimistic that researchers can find ways to deliver the therapies and reduce the costs, but he has grave concerns about the future of science, particularly in the US. He believes the recent wave of firings and funding cuts pose an existential threat to the next decade or two of progress that will have ramifications around the world. 'To me, slashing funding and people from science in the United States is like burning your seed corn. It's not even eating your seed corn. It's just destroying it,' he says. 'What can be more human than wanting to use all of our knowledge, all of our effort, all of our resources, to try to make the lives of our kids safer and better than our own lives? A huge part of that aspiration requires, and is indeed driven by, science.'
The Guardian
19-03-2025
- The Guardian
Cat owners asked to share pets' quirks for genetic study
Cat owners are being asked share their pet's quirky traits and even post researchers their fur in an effort to shed light on how cats' health and behaviour are influenced by their genetics. The scientists behind the project, Darwin's Cats, are hoping to enrol 100,000 felines, from pedigrees to moggies, with the DNA of 5,000 cats expected to be sequenced in the next year. The team say the goal is to produce the world's largest feline genetic database. 'Unlike most existing databases, which tend to focus on specific breeds or veterinary applications, Darwin's Cats is building a diverse, large-scale dataset that includes pet cats, strays and mixed breeds from all walks of life,' said Dr Elinor Karlsson, the chief scientist at the US non-profit organisation Darwin's Ark, director of the vertebrate genomics group at the Broad Institute of MIT and Harvard and associate professor at the UMass Chan Medical School. 'It's important to note, this is an open data project, so we will share the data with other scientists as the data set grows.' she added. The project follows on the heels of Darwin's Dogs, a similar endeavour that has shed light on aspects of canine behaviour, disease and the genetic origins of modern breeds. Darwin's Cats was launched in mid-2024 and already has more than 3,000 cats enrolled, although not all have submitted fur samples. Participants from all parts of the world are asked to complete a number of free surveys about their pet's physical traits, behaviour, environment, and health. However, at present, DNA kits – for owners to submit fur samples – can be sent only to US residents, and a donation of $199 (£160) is requested to cover the cost of sequencing and help fund the research. Karlsson added the team had developed a method to obtain high-quality DNA from loose fur without needing its roots – meaning samples can simply be collected by brushing. The researchers hope that by combining insights from cats' DNA with the survey results they can shed light on how feline genetics influences what cats look like, how they act and the diseases they experience. 'Understanding the genetics behind personality traits could even shed light on human neurodevelopmental conditions,' said Karlsson. The team also hopes to learn more about the genetic diversity of different breeds and unpick the ancestry of modern cats, with Karlsson adding she is particularly interested in many-toed cats. 'I'm really curious to find out how common this trait is in different parts of the world. I hope one day we might be able to combine that information with genetics to trace this trait back to its origins,' she said. A spokesperson for the charity International Cat Care (iCatCare), which is not involved in the work, said: 'We're really interested in the collaborative approach of Darwin's Ark, particularly in encouraging pet owners as community scientists to help advance the collective scientific understanding of cats as a species.' Dr Jeffrey Schoenebeck, of the Roslin Institute at the University of Edinburgh, also welcomed the . scheme. 'This is an important project that has the potential to improve our understanding of companion animals, the diseases that cause their morbidities, and the very nature of feline domestication,' he said.
